Relation Between Bone Mineral Density and IL-17 Serum Levels in Serbian Patients with Early Rheumatoid Arthritis

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2017 Mar 30

PMID 28352685

Citations 1

Authors

Voja Pavlovic

Aleksandar Dimic

Sasa Milenkovic

Dane Krtinic

Ivana Aleksic

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation and destruction of joint cartilage and bone. Different cytokines play important role in the processes that cause articular destruction and extra-articular manifestations in RA. The contribution of cytokines representing the Th1 (INF-γ), Th2 (IL-4) and IL-17A to the pathogenesis of early RA and bone mineral density (BMD) loss in still poorly understood. Serum samples of 38 early RA patients were evaluated for erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), C-reactive protein (CRP), anti-cyclic citrullinated peptide antibodies (anti-CCP) and for the tested cytokines (IL-17A, IL-4 and INF-γ). BMD was evaluated by dualenergy X-ray absorptiometry (DXA). Disease activity score (DAS28) calculation was assessed for all patients. Control serum samples were obtained from 34 healthy volunteers. The levels of tested cytokines were significantly higher (IL-17A, p<0.001; INF-γ, P<0.001; IL-4, P<0.01) in patients with early RA, compared to the healthy controls. In early RA patients, strong correlation of serum IL-17A was found with DAS28, ESR and CRP. Also, a significant negative correlation was found between serum INF-γ levels and the DAS28 score. Significantly positive correlation of BMD values and CRP, DAS28 IL-17A were also demonstrated. DXA analysis revealed that the most common site for osteoporosis was the lumbar spine followed by the femoral neck. BMD values significantly correlated with CRP, DAS28 score and IL-17A serum levels. The mean serum IL-17A levels, in patients with early RA, corresponded with disease activity, severity and BMD loss, indicating the potential usefulness of serum IL-17A in defining the disease activity and bone remodeling.

Citing Articles

Role of optical coherence tomography in the early detection of macular thinning in rheumatoid arthritis patients with chloroquine retinopathy.

Trenkic Bozinovic M, Babic G, Petrovic M, Karadzic J, Sarenac Vulovic T, Trenkic M J Res Med Sci. 2019; 24:55.

PMID: 31333734 PMC: 6611178. DOI: 10.4103/jrms.JRMS_704_18.

References

Lubberts E, Koenders M, van den Berg W . The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther. 2005; 7(1):29-37. PMC: 1064899. DOI: 10.1186/ar1478. View

Brennan F, McInnes I . Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008; 118(11):3537-45. PMC: 2575731. DOI: 10.1172/JCI36389. View

Colin E, Asmawidjaja P, van Hamburg J, Mus A, van Driel M, Hazes J . 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2009; 62(1):132-42. DOI: 10.1002/art.25043. View

Rosu A, Margaritescu C, Stepan A, Musetescu A, Ene M . IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients. Rom J Morphol Embryol. 2012; 53(1):73-80. View

Prevoo M, van t Hof M, Kuper H, van Leeuwen M, van de Putte L, van Riel P . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1):44-8. DOI: 10.1002/art.1780380107. View

Gullick N, Evans H, Church L, Jayaraj D, Filer A, Kirkham B . Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint. PLoS One. 2010; 5(9). PMC: 2931706. DOI: 10.1371/journal.pone.0012516. View

Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S . Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010; 62(2):383-91. DOI: 10.1002/art.27186. View

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

Book C, Karlsson M, Akesson K, Jacobsson L . Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol. 2008; 37(4):248-54. DOI: 10.1080/03009740801998747. View

10.

van Hamburg J, Asmawidjaja P, Davelaar N, Mus A, Colin E, Hazes J . Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2010; 63(1):73-83. DOI: 10.1002/art.30093. View

11.

Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S . IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999; 103(9):1345-52. PMC: 408356. DOI: 10.1172/JCI5703. View

12.

Green M, Deodhar A . Bone changes in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2001; 15(1):105-23. DOI: 10.1053/berh.2000.0129. View

13.

Gough A, Lilley J, Eyre S, Holder R, Emery P . Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994; 344(8914):23-7. DOI: 10.1016/s0140-6736(94)91049-9. View

14.

van der Heijde D, van t Hof M, van Riel P, Theunisse L, Lubberts E, van Leeuwen M . Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990; 49(11):916-20. PMC: 1004262. DOI: 10.1136/ard.49.11.916. View

15.

Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo C, Kolls J . IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 2003; 170(5):2655-62. DOI: 10.4049/jimmunol.170.5.2655. View

16.

Kroot E, Nieuwenhuizen M, de Waal Malefijt M, van Riel P, Laan R . Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum. 2001; 44(6):1254-60. DOI: 10.1002/1529-0131(200106)44:6<1254::AID-ART216>3.0.CO;2-G. View

17.

Tourinho T, Stein A, Castro J, Brenol J . Rheumatoid arthritis: evidence for bone loss in premenopausal women. J Rheumatol. 2005; 32(6):1020-5. View

18.

Dong W, Zhu P . Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics. Autoimmun Rev. 2012; 11(12):844-51. DOI: 10.1016/j.autrev.2012.02.019. View

19.

Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K . Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum. 1998; 41(9):1669-76. DOI: 10.1002/1529-0131(199809)41:9<1669::AID-ART19>3.0.CO;2-G. View

20.

Jurisic V, Terzic T, Pavlovic S, Colovic N, Colovic M . Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis. Pathol Res Pract. 2007; 204(2):129-32. DOI: 10.1016/j.prp.2007.09.001. View